ArticleJournal of hematology & oncology2020

Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity.

Tracy C Kuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.